SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Dogecoin (DOGE) is a cryptocurrency . Users are able to generate DOGE through the process of mining. Dogecoin has a current supply of 156,752,062,860.16806072. The last known price of Dogecoin is 0.05689686 USD and is down -11.89 over the last 24 hours. It is currently trading on 1545 active market(s) with $1,128,721,930.78 traded over the last 24 hours. More information can be found at http://dogecoin.com/.

Dogecoin

Dogecoin is drawing attention amid a steep decline alongside the broader crypto market, with traders discussing multi-year lows and persistent selling pressure. The community is split between buying the dip and expecting further losses, with bearish posts citing DOGEs limited utility and bulls arguing the selloff may create an accumulation opportunity.

Avalanche (AVAX) is a cryptocurrency launched in 2020. Avalanche has a current supply of 471,438,169.1160568 with 446,436,169.1160568 in circulation. The last known price of Avalanche is 6.99518175 USD and is down -15.00 over the last 24 hours. It is currently trading on 1135 active market(s) with $402,139,637.32 traded over the last 24 hours. More information can be found at https://avax.network/.

Avalanche

A sharp crypto selloff, which traders largely link to Bitcoin weakness and broader altcoin pressure, has put AVAX under renewed scrutiny; many complain it is falling harder than peers and failing to hold rebounds, while others view the dip as a buying opportunity. Some also question why positive institutional-tokenization developments have not translated into sustained strength for the token.

XRP (XRP) is a cryptocurrency . XRP has a current supply of 99,985,583,260 with 63,516,606,953 in circulation. The last known price of XRP is 0.92173784 USD and is down -8.73 over the last 24 hours. It is currently trading on 1896 active market(s) with $4,059,642,828.82 traded over the last 24 hours. More information can be found at https://xrpl.org/.

Ripple

A broad crypto selloff, with traders pointing to Bitcoin weakness and leveraged liquidations, has driven XRP to fresh 52-week lows. The conversation is split between holders buying the dip and bearish traders warning of further declines, with many describing the drop as part of a wider market downturn.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Traders are focused on the FDAs pending decision on ivonescimab for EGFR-mutated lung cancer, with the stock treated as a high-risk approval-or-rejection event. The debate centers on strong progression-free-survival results and improving follow-up survival data versus the trials primary overall-survival analysis narrowly missing statistical significancea regulatory concern bulls view as potentially outweighed by the broader evidence, while bears see it as a major approval hurdle.

Delta Air Lines, Inc. engages in the provision of scheduled air transportation for passengers and cargo. It operates through the Airline and Refinery segments. The Airline segment provides scheduled air transportation for passengers and cargo. The Refinery segment provides jet fuel to the airline segment. The company was founded by Collett Everman Woolman in 1928 and is headquartered in Atlanta, GA.

Delta Air Lines, Inc.

A nationwide FAA ground stop caused by air-traffic-control communications failures is dominating discussion, with traders weighing ongoing cancellations and disruption costs against the fact that the grounding was lifted. Some posts speculate about cyberattacks or political motives, but those claims are unverified.

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.

Bristol-Myers Squibb Co.

Bristol Myers Squibbs quarterly results drew attention, with revenue and adjusted earnings ahead of expectations and a higher revenue outlook, alongside lower EPS guidance reflecting licensing-related charges. Traders are weighing the growth portfolios momentum against patent-expiration risks, with some also citing weak chart action.

Modine Manufacturing Co. engages in the provision of thermal management products and solutions. It operates through the Climate Solutions and Performance Technologies business segments. The Climate Solutions segment provides climate-controlled solutions and components, heat transfer products, heating, ventilating, air conditioning and refrigeration products, and data center cooling solutions. The Performance Technologies segment designs and manufactures air- and liquid-cooled technology for vehicular, stationary power, and industrial applications. In addition, the Performance Technologies segment provides thermal solutions to zero-emission and hybrid commercial vehicle and automotive customers, and coating products and application services. The company was founded by Arthur B. Modine on June 23, 1916 and is headquartered in Racine, WI.

Modine Manufacturing Co.

MOD surged on reports that Samsung is in talks to acquire the data-center cooling company, though neither a deal nor terms have been confirmed. Traders are split between expecting a substantial takeover premium, given Modines AI-cooling prospects, and warning that the spike could fade if talks fall through or a potential offer falls below the current share price.

Zcash (ZEC) is a cryptocurrency . Users are able to generate ZEC through the process of mining. Zcash has a current supply of 16,965,784.04290557. The last known price of Zcash is 859.04777304 USD and is down -7.89 over the last 24 hours. It is currently trading on 671 active market(s) with $1,007,600,218.89 traded over the last 24 hours. More information can be found at https://z.cash/.

Zcash

Zcash is drawing attention after a steep, volatile pullback from its earlier rally, with traders split between calling a bottom and expecting further declines. Some see the NU7 network upgrade and Zcashs privacy focus as reasons for renewed interest, while others remain concerned about weak price action and broader crypto-market pressure.

Ethereum (ETH) is a cryptocurrency . Ethereum has a current supply of 122,218,624.4003947. The last known price of Ethereum is 1,739.90377069 USD and is down -9.84 over the last 24 hours. It is currently trading on 14359 active market(s) with $18,820,901,710.98 traded over the last 24 hours. More information can be found at https://www.ethereum.org/.

Ethereum

Ethereum is caught in a sharp, broad crypto selloff, with traders pointing to Bitcoins weakness, leveraged-long liquidations and wider risk-off pressure; some speculate investors are freeing cash for the Anthropic IPO, but that explanation is unconfirmed. The community is split between warnings of further downside and calls that the drop is capitulation and a buying opportunity.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Unconfirmed buyout or partnership speculationoften naming Novo Nordisk or other large drugmakersis driving much of the attention, alongside discussion of Vikings VK2735 presentations at ObesityWeek. Traders are split between hopes for a deal and skepticism that any talks are real, with others emphasizing that the pivotal Phase 3 results remain the key catalyst.

statis crypto Watchlist

Bitcoin

Solana

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
